88 related articles for article (PubMed ID: 23270679)
1. [Hypersensitivity to radiation therapy in a patient with tuberous sclerosis: biological considerations about a clinical case].
Duchemann B; Wong S; Baruch-Hennequin V; Rivera S; Quero L; Hennequin C
Cancer Radiother; 2013 Feb; 17(1):50-3. PubMed ID: 23270679
[TBL] [Abstract][Full Text] [Related]
2. Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma.
Chen J; Pan J; Liu J; Li J; Zhu K; Zheng X; Chen M; Chen M; Liao Z
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):671-7. PubMed ID: 23773390
[TBL] [Abstract][Full Text] [Related]
3. Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2).
Higuchi K; Komori S; Tanabe S; Katada C; Azuma M; Ishiyama H; Sasaki T; Ishido K; Katada N; Hayakawa K; Koizumi W;
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):872-9. PubMed ID: 24867539
[TBL] [Abstract][Full Text] [Related]
4. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.
Driessen CM; de Boer JP; Gelderblom H; Rasch CR; de Jong MA; Verbist BM; Melchers WJ; Tesselaar ME; van der Graaf WT; Kaanders JH; van Herpen CM
Eur J Cancer; 2016 Jan; 52():77-84. PubMed ID: 26655558
[TBL] [Abstract][Full Text] [Related]
6. A retrospective, multicenter study of the tolerance of induction chemotherapy with docetaxel, Cisplatin, and 5-Fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of squamous cell carcinoma of the head and neck.
Buiret G; Combe C; Favrel V; Pommier P; Martin L; Ecochard R; Fayette J; Tartas S; Ramade A; Céruse P
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):430-7. PubMed ID: 19775831
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
8. [Clinical effects of concurrent chemoradiotherapy (hyperfractionation and cisplatin/5-fluorouracil) for patients with advanced oral squamous cell carcinoma].
Tsuchiya Y; Noguchi T; Matsumoto K; Matsumura T; Hoshi K; Ito H; Osano H; Jinbu Y; Kusama M
Gan To Kagaku Ryoho; 2009 Jan; 36(1):101-3. PubMed ID: 19151572
[TBL] [Abstract][Full Text] [Related]
9. Tuberous sclerosis complex.
Hasbani DM; Crino PB
Handb Clin Neurol; 2018; 148():813-822. PubMed ID: 29478616
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma].
Xie FY; Qi SN; Hu WH; Zou GR; Peng M; Li JS
Ai Zheng; 2007 Aug; 26(8):880-4. PubMed ID: 17697552
[TBL] [Abstract][Full Text] [Related]
11. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.
Kachnic LA; Tsai HK; Coen JJ; Blaszkowsky LS; Hartshorn K; Kwak EL; Willins JD; Ryan DP; Hong TS
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):153-8. PubMed ID: 21095071
[TBL] [Abstract][Full Text] [Related]
12. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus.
Ohtsu A; Boku N; Muro K; Chin K; Muto M; Yoshida S; Satake M; Ishikura S; Ogino T; Miyata Y; Seki S; Kaneko K; Nakamura A
J Clin Oncol; 1999 Sep; 17(9):2915-21. PubMed ID: 10561371
[TBL] [Abstract][Full Text] [Related]
13. [Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy].
Troussier I; Huguet F; Servagi-Vernat S; Benahim C; Khalifa J; Darmon I; Ortholan C; Krebs L; Dejean C; Fenoglietto P; Vieillot S; Bensadoun RJ; Thariat J
Cancer Radiother; 2015 Apr; 19(2):127-38. PubMed ID: 25770884
[TBL] [Abstract][Full Text] [Related]
14. [Ototoxicity in head and neck cancers after radiotherapy and chemoradiotherapy: From primary prevention to tertiary prevention].
Espenel S; Garcia MA; Guy JB; Vallard A; Ben Mrad M; Langrand-Escure J; El Meddeb Hamrouni A; Trone JC; Xia Y; Rancoule C; Magné N
Cancer Radiother; 2017 Feb; 21(1):77-83. PubMed ID: 28189351
[TBL] [Abstract][Full Text] [Related]
15. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
Tahara M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel, cisplatin and 5-fluorouracil chemotherapy with concurrent radiation for unresectable advanced urethral carcinoma.
Itoh J; Mitsuzuka K; Kimura S; Tanaka T; Yamamuro T; Yamashita S; Yamada S; Saito H; Kaiho Y; Arai Y
Int J Urol; 2014 Apr; 21(4):422-4. PubMed ID: 24251859
[TBL] [Abstract][Full Text] [Related]
17. [Constraints of the dentist are consistent with the results of an optimal irradiation with modulated intensity in N0 oropharyngeal cancer].
Jaussaud S; Guihard S; Niederst C; Borel C; Meyer P; Hémar P; Schultz P; Noël G; Féki A
Cancer Radiother; 2013; 17(4):265-71. PubMed ID: 23726044
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340
[TBL] [Abstract][Full Text] [Related]
19. Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases.
Mitsudo K; Koizumi T; Iida M; Iwai T; Oguri S; Yamamoto N; Itoh Y; Kioi M; Hirota M; Tohnai I
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e639-45. PubMed ID: 22543212
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
